Sesame Care vs Henry Meds
All-in cost at every dose, fee structure, care model, pharmacy disclosure and terms — compared on one basis.
Only Henry Meds publishes a price we could capture ($1,788 for a first year at a maintenance dose). The other does not, so this comparison cannot be settled on cost.
What can be compared is what each discloses: visit model, pharmacy identity, laboratory requirement and cancellation terms. Those are below.
All-in monthly cost = medication + any recurring fee, at a named dose, before tax and before prepaid discounts. Captured 2026-08-05. How we verify a price.
Sesame Care vs Henry Meds at every dose
A single headline figure assumes a maintenance dose neither you nor your prescriber has chosen yet. This is the same comparison at all six strengths.
Sesame Care against Henry Meds at every dose
| Dose | Sesame Care | Henry Meds | Cheaper |
|---|---|---|---|
| 0.25 mg | — | $149 | — |
| 0.5 mg | — | $149 | — |
| 1 mg | — | $149 | — |
| 1.7 mg | — | $149 | — |
| 2.4 mg | — | $149 | — |
What differs beyond price
Price is the easiest thing to compare and rarely the thing that decides satisfaction. These are the attributes each programme publishes.
| Attribute | Sesame Care | Henry Meds |
|---|---|---|
| Pricing model | model unknown | flat at every dose |
| Membership | none | none |
| Prepaid rate | none published | none published |
| Visit model | not published | async |
| Labs | not published | not required |
| Pharmacy disclosure | not published | not named |
| Cancellation | not published | check terms |
| Regulatory status | compounded, not FDA-approved | compounded, not FDA-approved |
| Evidence status | no price published | third-party figure |
Which one, for whom
If you want the lowest total cost: neither can be ranked on cost until both publish a price.
If you want budget certainty: Henry Meds, which holds one price at every strength.
If you want to verify the supply chain: Henry Meds, which names its dispensing pharmacy.
If you may need to stop early: compare the cancellation rows above before prepaying. Compounded medication is generally not refundable once it has shipped, so a multi-month term is the wrong structure during titration, when intolerance is the most likely reason to stop.
Switching between them
Usually possible after a clinical review, and the two real risks are a supply gap while a new intake is processed and a new prescriber restarting titration rather than continuing your dose. Confirm dose continuity in writing before cancelling anything, because a month back at 0.25 mg is a month of lost progress no price difference recovers.
Fee structure, side by side
Sesame Care charges no recurring fee on top of medication. Henry Meds charges no recurring fee.
This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.
Care model and what it buys
Sesame Care: visit model not published, labs not published, coaching not published. Henry Meds: async, labs not required, none published.
Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.
Verification, which outranks both
Sesame Care: pharmacy not disclosed. Henry Meds: not named.
A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.
What can still be decided here
Without a price on both sides this cannot be settled on cost, so it has to be settled on what each programme publishes — which is frequently the better basis anyway.
Sesame Care publishes: visit model not stated, laboratory requirement not stated, pharmacy not stated, cancellation not stated. Henry Meds publishes: visit model async, laboratory requirement not required, pharmacy not named, cancellation check terms.
A programme publishing four of those and one publishing none are not equally knowable, and that asymmetry is a finding rather than a gap in our research. Ask both for the total at 2.4 mg including every fee, in writing, and see which answers.
Why a missing price is itself information
A programme that publishes its price is making a claim it can be held to. A programme that reveals cost only after an intake has made a commercial choice: it wants your contact details and a medical history before you can compare it against anything.
That is legal and common. It is also why several pages on this site carry an explanation instead of a number. Estimating would mean inventing the only figure that matters, and every time we have checked an estimate published elsewhere against a provider's own page, the estimate was low.
How much sesame care and henry meds should weigh
Less than the dose question and more than the brand. 19 of 20 programmes hold one price from 0.25 mg to 2.4 mg; the rest reprice as you climb. Which group you choose changes a twelve-month total more than almost any other single decision.
That is because semaglutide titrates slowly. Sixteen weeks minimum to a maintenance dose, frequently longer for tolerability, and a dose-scaled programme reprices you at every step of it.
Flat pricing is worst value at the bottom of the ladder and best at the top, which makes it less a lower price than insurance against a decision your prescriber has not made yet.
What a well-run programme publishes
Its price at every strength. Its pharmacy. Its prescriber's licensure. Its cancellation notice period. And which form of the active ingredient it compounds from, because FDA has distinguished semaglutide base from salt forms and linked the salts to safety concerns.
That last one is specific to this molecule and almost never asked. Programmes that answer it precisely are telling you how closely they supervise their supply chain.
The failure mode this section guards against
Choosing a programme on a number that describes a different situation than yours. An entry price when you will hold maintenance. A medication figure when a membership applies. A promotional rate when you will renew.
Each error is small alone and they compound in one direction, which is why the cheapest-looking option in most published comparisons is the one most likely to be mis-stated. Priced correctly the cheapest verified route sits at $145 a month all-in at a 2.4 mg maintenance dose.
Why we publish the working rather than a verdict
A single recommendation reads better and acts worse, because it hides the weighting. Two readers with different maintenance doses, different coverage and different tolerance for commitment should not receive the same answer.
So the tables carry the inputs and every ranking states its sort key. Disagree with our weighting and you can take the file and weight it yourself — which is what publishing it is for.
The number most people get wrong
The month-six figure. Almost everyone budgets from the first month, which on semaglutide describes four weeks at 0.25 mg — roughly 1 mg of active drug against the 9.6 mg a maintenance month delivers.
Ten of your first twelve months are spent at or near maintenance. A ranking sorted on the advertised month is sorting on about eight per cent of your year, and on a dose-scaled programme those are different numbers entirely.
Run the first-year calculator at the dose you expect to hold. It takes under a minute and it reorders the market for most people.
What a year of this actually looks like
Four weeks at 0.25 mg, four at 0.5 mg, four at 1 mg, four at 1.7 mg, then 2.4 mg for the remainder. Sixteen weeks of titration if nothing is repeated, and repeats are common rather than exceptional.
Budget two extra months at a lower tier and treat anything better as upside. Fix a weekly injection day, record dose and date, and diary the renewal date if an introductory rate applies — the reversion is where most complaints in this category begin.
Why this comparison cannot be settled on price
Only Henry Meds publishes a price we could capture, at about $1,788 for a first year at a maintenance dose. The other does not. A comparison that filled that gap with an estimate would be inventing the only number that matters.
What can be compared is what each discloses before you pay, and that is frequently the more useful comparison anyway. A programme that names its pharmacy, states its cancellation terms and publishes a price at every dose has told you how it will behave when something goes wrong.
What to do instead
Ask both for the total at 2.4 mg including every fee, in writing, and compare the replies against the programmes that already publish. If one answers in a sentence and the other does not answer at all, you have your comparison.
Why we publish the page anyway
Because the absence is the finding. Someone searching for this pairing deserves to know that one side cannot be priced, rather than being shown a fabricated number or no page at all.
Fee structure, side by side
Sesame Care charges no recurring fee on top of medication. Henry Meds charges no recurring fee.
This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.
Care model and what it buys
Sesame Care: visit model not published, labs not published, coaching not published. Henry Meds: async, labs not required, none published.
Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.
Verification, which outranks both
Sesame Care: pharmacy not disclosed. Henry Meds: not named.
A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.
What can still be decided here
Without a price on both sides this cannot be settled on cost, so it has to be settled on what each programme publishes — which is frequently the better basis anyway.
Sesame Care publishes: visit model not stated, laboratory requirement not stated, pharmacy not stated, cancellation not stated. Henry Meds publishes: visit model async, laboratory requirement not required, pharmacy not named, cancellation check terms.
A programme publishing four of those and one publishing none are not equally knowable, and that asymmetry is a finding rather than a gap in our research. Ask both for the total at 2.4 mg including every fee, in writing, and see which answers.
Why a missing price is itself information
A programme that publishes its price is making a claim it can be held to. A programme that reveals cost only after an intake has made a commercial choice: it wants your contact details and a medical history before you can compare it against anything.
That is legal and common. It is also why several pages on this site carry an explanation instead of a number. Estimating would mean inventing the only figure that matters, and every time we have checked an estimate published elsewhere against a provider's own page, the estimate was low.
How much sesame care and henry meds should weigh
Less than the dose question and more than the brand. 19 of 20 programmes hold one price from 0.25 mg to 2.4 mg; the rest reprice as you climb. Which group you choose changes a twelve-month total more than almost any other single decision.
That is because semaglutide titrates slowly. Sixteen weeks minimum to a maintenance dose, frequently longer for tolerability, and a dose-scaled programme reprices you at every step of it.
Flat pricing is worst value at the bottom of the ladder and best at the top, which makes it less a lower price than insurance against a decision your prescriber has not made yet.
What a well-run programme publishes
Its price at every strength. Its pharmacy. Its prescriber's licensure. Its cancellation notice period. And which form of the active ingredient it compounds from, because FDA has distinguished semaglutide base from salt forms and linked the salts to safety concerns.
That last one is specific to this molecule and almost never asked. Programmes that answer it precisely are telling you how closely they supervise their supply chain.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.
Compare every programme on one screen
The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.
Common questions
Is Sesame Care or Henry Meds cheaper?
Only one of the two publishes a price we could capture, so this comparison cannot be settled on cost. Both are compared on terms and disclosure instead.
Do Sesame Care and Henry Meds charge a membership on top of medication?
Sesame Care: no. Henry Meds: no. Every figure on this page includes it where charged.
Does Sesame Care or Henry Meds name its dispensing pharmacy?
Sesame Care: not published. Henry Meds: not named. It is the disclosure that lets you check a state board register before you inject anything weekly.
Can I switch between them mid-treatment?
Usually yes, after a clinical review. Confirm dose continuity in writing and do not cancel the old programme until the new one has shipped, because a supply gap costs more than a price difference.
Is either Sesame Care or Henry Meds FDA-approved?
Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality before marketing. Where a programme supplies brand product, that product is approved; the programme around it is not a regulated entity in the same sense.